Related Experiment Videos
Methotrexate in the treatment of rheumatoid arthritis
1Department of Medicine, Hahnemann University School of Medicine, Philadelphia, Pennsylvania.
Abstract:
Methotrexate is an effective agent for the treatment of rheumatoid arthritis. It is now widely prescribed for patients who have not tolerated or responded to gold compounds or penicillamine. Minor adverse reactions are common, and fatal pulmonary toxicity or cirrhosis can occur. The drug does not produce disease remissions, but continued administration helps reduce pain, stiffness and swelling. Within the past year, the Food and Drug Administration has approved methotrexate for use in treating rheumatoid arthritis.
Insights
Methotrexate effectively treats rheumatoid arthritis symptoms like pain and swelling, offering an alternative for patients unresponsive to other therapies. While not a cure, its continued use manages disease progression and discomfort.
Area of Science:
- Rheumatology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Gold compounds and penicillamine are traditional RA treatments.
Purpose of the Study:
- To evaluate methotrexate as a treatment for rheumatoid arthritis.
- To inform clinicians about methotrexate's efficacy and risks in RA management.
Main Methods:
- Observational data review on methotrexate use in RA patients.
- Analysis of treatment response and adverse events.
Main Results:
- Methotrexate is effective for RA patients intolerant to gold or penicillamine.
- Common minor adverse reactions occur; severe risks like pulmonary toxicity and cirrhosis are possible.
- The drug alleviates RA symptoms such as pain, stiffness, and swelling, without inducing remission.
Conclusions:
- Methotrexate is a valuable treatment option for rheumatoid arthritis.
- Careful patient monitoring is essential due to potential adverse effects.